Bisphosphonates and radiation therapy for palliation of metastatic bone disease
Author:
- 1 August 2003
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 29 (4) , 321-327
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- 8 Gy single fraction radiotherapy for the treatment of metastatic skeletal pain: randomised comparison with a multifraction schedule over 12 months of patient follow-upOn behalf of the Bone Pain Trial Working PartyRadiotherapy and Oncology, 1999
- Should bisphosphonates be part of the standard therapy of patients with multiple myeloma or bone metastases from other cancers? An evidence-based review.Journal of Clinical Oncology, 1998
- Radiotherapy for bone painPain, 1995
- Retreatment with radiotherapy for painful bone metastasesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1994
- A comparison of the palliative effects of strontium-89 and external beam radiotherapy in metastatic prostate cancerRadiotherapy and Oncology, 1994
- A prospective randomised trial of 4 Gy or 8 Gy single doses in the treatment of metastatic bone painRadiotherapy and Oncology, 1992
- Palliation of bone metastases in prostate cancer. Hemibody irradiation or strontium-89?Clinical Oncology, 1992
- Hemibody irradiation (HBI) for metastatic bone pain in two histologically distinct groups of patientsClinical Oncology, 1989
- The responsiveness of bone metastases to radiotherapy: The effect of site, histology and radiation dose on pain reliefRadiotherapy and Oncology, 1989
- Intrinsic radiosensitivity of human cell lines is correlated with radioresponsiveness of human tumors: Analysis of 101 published survival curvesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1985